Farther Finance Advisors LLC Buys 2,629 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Farther Finance Advisors LLC increased its stake in Intuitive Surgical by 81.7%, acquiring an additional 2,629 shares to reach a total of 5,845 shares valued at approximately $3.18 million.
• Insider trading activity included Director Amy L. Ladd selling 336 shares at an average price of $470.11 and CEO Gary S. Guthart selling 29,360 shares at around $472.49, affecting their ownership stakes significantly.
• Analysts have mixed views on Intuitive Surgical, with an average rating of "Moderate Buy" and a consensus price target raised to $595.00, although some analysts have downgraded their ratings to "hold."

Farther Finance Advisors LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 81.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,845 shares of the medical equipment provider's stock after acquiring an additional 2,629 shares during the period. Farther Finance Advisors LLC's holdings in Intuitive Surgical were worth $3,176,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. AlphaCore Capital LLC grew its holdings in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the last quarter. Aaron Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock valued at $1,374,000 after acquiring an additional 19 shares during the last quarter. Crown Wealth Group LLC boosted its holdings in Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after acquiring an additional 20 shares during the last quarter. FSM Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after acquiring an additional 20 shares during the last quarter. Finally, CFO4Life Group LLC boosted its holdings in Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after acquiring an additional 20 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Activity

In other news, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Piper Sandler reiterated an "overweight" rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. UBS Group raised their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $438.72 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market capitalization of $157.27 billion, a P/E ratio of 61.19, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61. The stock has a fifty day moving average of $476.64 and a 200-day moving average of $503.43.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.78 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.